Novo Chairman Faces Testy Investors With Little Progress So Far

Novo Nordisk A/S’s Chairman Lars Rebien Sorensen will face investors at the company’s annual meeting for the first time on Thursday after his boardroom coup. He’s in for an earful.

By Naomi Kresge, Lisa Pham, Sara Sjolin · Bloomberg Markets

Novo Nordisk A/S’s Chairman Lars Rebien Sorensen will face investors at the company’s annual meeting for the first time on Thursday after his boardroom coup. He’s in for an earful.